(Q34424030)

2 August 2017

title

CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival (English)

1 reference

2 August 2017

0 references

1 reference

Wei-Peng He

1

1 reference

2 August 2017

Juan Zhou

2

1 reference

2 August 2017

Mu-Yan Cai

3

1 reference

2 August 2017

Xiang-Shen Xiao

4

1 reference

2 August 2017

Yi-Ji Liao

5

1 reference

2 August 2017

Hsiang-Fu Kung

6

1 reference

2 August 2017

Xin-Yuan Guan

7

1 reference

2 August 2017

Dan Xie

8

1 reference

2 August 2017

Guo-Fen Yang

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

29 September 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

page(s)

437

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-12-437

2 August 2017

exact match

0 references

cites work

Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

6 July 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Treatment of ovarian cancer: new strategies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

6 July 2018

Update in women's health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Characterization of the CHD family of proteins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Overexpression of clusterin in ovarian cancer is correlated with impaired survival.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-437

Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-437

PARylation: strengthening the connection between cancer and pluripotency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-437

Genetics and ovarian carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551745

Heterogeneous expression and association of ?-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-437

Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23020525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23020525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-12-437

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference